Tag: PCR e-Course 2020
Study shows LAAO reduces major bleeding and mortality compared with NOACs in high-risk AF patients
Jens Erik Nielsen-Kudsk (Aarhus, Denmark) speaks to Cardiovascular News about a propensity score...
PCR e-Course 2020: Two-year outcomes of deferred revascularisation based on FFR or iFR measurements “virtually identical”
Mid-term data continue to show non-inferiority of resting instantaneous wave-free ratio (iFR) wh...
PCR e-Course 2020: P2Y12 inhibitor monotherapy associated with increased risk of cardiac death after PCI
A subanalysis of the Onyx One study found that cardiac death was significantly higher in patient...
PCR e-Course 2020: Roll-in trial finds high device success rate for Amplatzer Amulet occlusion device
Left atrial appendage occlusion (LAAO) using the Amplatzer Amulet (Abbott) device has a high imp...
PCR e-Course 2020: Bicuspid TAVI is feasible, safe and efficient
The feasibility, safety, and efficiency of transcatheter aortic valve implantation (TAVI) using ...
PCR e-Course 2020: Data for Ultimaster reinforce safety and efficacy of device
According to a press release, one-year total population clinical outcome data from e-ULTIMASTER—...
PCR e-Course 2020: Cangrelor provided inferior inhibitor of platelet aggregation than tirofiban in STEMI patients
The FABOLUS FASTER trial, which was presented at PCR e-Course 2020 and simultaneously published ...
PCR e-Course 2020: CoFI system may address microvascular obstruction after primary PCI
Felice Gragnano (Inselspital, Bern University Hospital, Bern, Switzerland) outlined at PCR e-Cou...
PCR e-Course 2020: Left atrial appendage occlusion improves clinical outcomes vs NOACs in high risk AF patients
Left atrial appendage occlusion (LAAO) improves clinical outcomes including ischaemic stroke, ma...
PCR e-Course 2020: Routine revascularisation confers no survival advantage over initial medical therapy in patients with stable disease
Sripal Bangalore (New York University Grossman School of Medicine, New York, USA) presented the ...
PCR e-Course 2020: Reduction in tricuspid regurgitation with TriClip edge-to-edge repair is sustained at one year
One-year results from the TRILUMINATE study show that TriClip (Abbott) transcatheter therapy for...
PCR e-Course 2020: DynamX Bioadaptor shows “excellent” safety and efficacy at 12 months
Clinical and imaging results at 12 months for the DynamX Novolimus-Eluting Coronary Bioadaptor s...
PCR e-Course 2020: DEFINITION II finds two-stent approach better than provisional in complex lesions
A systematic two-stent approach in complex coronary bifurcation lesions is associated with a sig...
PCR e-Course 2020: Sham patients from RADIANCE-HTN SOLO who crossed over to denervation had reduced blood pressure
Patients who crossed over from the sham control arm of the RADIANCE-HTN SOLO trial to the renal ...
PCR e-Course 2020: Evolut Low-Risk trial confirms TAVI is non-inferior to surgery, and establishes it is cost-effective
Full one-year follow-up from the Evolut Low Risk trial has upheld earlier findings from the study, d...
First evaluation of long-term outcomes after aortic valve-in-valve presented at PCR e-Course 2020
Long-term clinical outcomes, including mortality, following an aortic valve-in-valve procedure m...
PCR e-Course 2020: Evoque demonstrates feasibility for mitral valve replacement via a transseptal approach
Use of the transseptal Evoque transmitral valve replacement (TMVR) system (Edwards Lifesciences)...
PCR e-Course 2020: Mitral valve-in-valve and valve-in-ring strategies often require repeat procedures
A comprehensive evaluation of mitral valve-in-valve (ViV) and valve-in-ring (ViR) procedures has...
